newsfilter
← Latest News
GlobeNewswire·

GH Research Provides Business Updates and Highlights Key Upcoming Milestones

Initial approvals received for Phase 2b trial of GH001 in TRD (GH001-TRD-201), initiation of this trial expected in Q1 2023Development of proprietary aerosol delivery device for GH001 progressed, IND submission with this